See New Dosage Map New! The ClinGen Dosage Sensitivity curations and downloads that are available at this site are now also available at www.clinicalgenome.org. Click on the button to access Dosage Sensitivity in the context of ClinGen's other curated information, including Gene-Disease Validity and Clinical Actionability.
No evidence was found to suggest that loss of function of OSBPL5 results in a specific phenotype. One study has shown that this gene is imprinted in the placenta of both mice and humans, but not other tissues (PMID:12504849), while another counters that it is not imprinted in human trophoblast stem cells (PMID:20644730). Neither study proposed a specific human phenotype associated with changes in imprinting within this gene.
No evidence was found to suggest that duplications of OSBPL5 result in a specific phenotype. One study has shown that this gene is imprinted in the placenta of both mice and humans, but not other tissues (PMID:12504849), while another counters that it is not imprinted in human trophoblast stem cells (PMID:20644730). Neither study proposed a specific human phenotype associated with changes in imprinting within this gene.